IL112995A - Recombinant inhibitor from erythrina caffra with increased activity and process for purifying serine proteases using the same - Google Patents

Recombinant inhibitor from erythrina caffra with increased activity and process for purifying serine proteases using the same

Info

Publication number
IL112995A
IL112995A IL11299595A IL11299595A IL112995A IL 112995 A IL112995 A IL 112995A IL 11299595 A IL11299595 A IL 11299595A IL 11299595 A IL11299595 A IL 11299595A IL 112995 A IL112995 A IL 112995A
Authority
IL
Israel
Prior art keywords
polypeptide
inhibitor
sequence
seq
activity
Prior art date
Application number
IL11299595A
Other languages
English (en)
Other versions
IL112995A0 (en
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4424171A external-priority patent/DE4424171A1/de
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of IL112995A0 publication Critical patent/IL112995A0/xx
Publication of IL112995A publication Critical patent/IL112995A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6459Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114Kunitz type inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21069Protein C activated (3.4.21.69)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/814Enzyme separation or purification
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/814Enzyme separation or purification
    • Y10S435/815Enzyme separation or purification by sorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
IL11299595A 1994-03-16 1995-03-14 Recombinant inhibitor from erythrina caffra with increased activity and process for purifying serine proteases using the same IL112995A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4408939 1994-03-16
DE4424171A DE4424171A1 (de) 1994-03-16 1994-07-08 Verwendung von rekombinantem Inhibitor aus Erythrina caffra zur Reinigung von Serinproteasen

Publications (2)

Publication Number Publication Date
IL112995A0 IL112995A0 (en) 1995-06-29
IL112995A true IL112995A (en) 2004-07-25

Family

ID=25934769

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11299595A IL112995A (en) 1994-03-16 1995-03-14 Recombinant inhibitor from erythrina caffra with increased activity and process for purifying serine proteases using the same

Country Status (14)

Country Link
US (1) US5958722A (fr)
EP (1) EP0750667B1 (fr)
JP (1) JP2846961B2 (fr)
AT (1) ATE174962T1 (fr)
AU (1) AU691904B2 (fr)
CA (1) CA2185436C (fr)
CZ (1) CZ285502B6 (fr)
ES (1) ES2128721T3 (fr)
IL (1) IL112995A (fr)
MX (1) MX9603864A (fr)
NO (1) NO316704B1 (fr)
NZ (1) NZ282790A (fr)
SK (1) SK282430B6 (fr)
WO (1) WO1995025168A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3382389D1 (de) * 1982-12-14 1991-10-02 South African Inventions Plasminogenaktivator.
DE3689927T3 (de) * 1985-10-04 1998-10-22 South African Inventions Reagens und Verfahren.

Also Published As

Publication number Publication date
ES2128721T3 (es) 1999-05-16
CZ285502B6 (cs) 1999-08-11
CA2185436C (fr) 2000-08-01
EP0750667B1 (fr) 1998-12-23
NO963849D0 (no) 1996-09-13
WO1995025168A1 (fr) 1995-09-21
ATE174962T1 (de) 1999-01-15
CA2185436A1 (fr) 1995-09-21
NZ282790A (en) 1997-08-22
CZ252996A3 (en) 1996-11-13
SK114296A3 (en) 1997-05-07
JP2846961B2 (ja) 1999-01-13
SK282430B6 (sk) 2002-02-05
AU2069395A (en) 1995-10-03
MX9603864A (es) 1997-03-29
EP0750667A1 (fr) 1997-01-02
NO316704B1 (no) 2004-04-13
US5958722A (en) 1999-09-28
NO963849L (no) 1996-11-15
JPH09503395A (ja) 1997-04-08
IL112995A0 (en) 1995-06-29
AU691904B2 (en) 1998-05-28

Similar Documents

Publication Publication Date Title
US4865974A (en) Bacterial methionine N-terminal peptidase
JP2561708B2 (ja) 新規な組織プラスミノーゲン活性化因子
JPH07147984A (ja) ポリクリングルプラスミノーゲン活性化因子をコードする遺伝子およびそれを含有するベクター
CA2254647C (fr) Serines proteases chimeres
US5013662A (en) Bacterial methionine n-terminal peptidase
US5210028A (en) Process for the production of unfused igf-ii protein in e. coli
EP1024192B1 (fr) Streptokinases spécifiques du thrombus à la coagulation possédant des charactéristiques d'activation du plasminogène modifiées et un procédé pour leur préparation
WO1987005934A1 (fr) Analogues de proteine d'un activateur de plasminogene tissulaire
CA2215531C (fr) Mutant de l'inhibiteur du type erythrina caffra et son utilisation pour la purification des serine-proteases
CA2185436C (fr) Utilisation d'un inhibiteur recombine issu d'erythrina caffra pour purifier des serine proteases
JP2509410B2 (ja) 組換えIgA−プロテア―ゼの製法、組換えDNA、組換えベクタ―、細胞
KR100206731B1 (ko) 에리트리나 카프라 유래 재조합 억제인자를 이용한 세린 프로테아제의 정제방법
EP0342658A1 (fr) Procédé biosynthétique de préparation de produits chimiques
US5840517A (en) Process for preparing obesity protein analogs
MXPA97007486A (en) Mutant of the type erythrina caffra inhibitor and the use of said mutant to purify proteases of being
US5700677A (en) Protein analogues of tissue plasminogen activator
Brünen-Nieweler et al. Expression of the pheromone 3-encoding gene of Euplotes octocarinatus using a novel bacterial secretion vector
JPH0648988B2 (ja) トロンビン阻害物質の製造法

Legal Events

Date Code Title Description
ERR Corrigendum

Free format text: JOURNAL 5/04 P. 1765 PATENT APPLICATION NO. 112995 CORRECT TITLE OF INVENTION TO:

FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired